scispace - formally typeset
S

Shira G. Ziegler

Researcher at Johns Hopkins University School of Medicine

Publications -  33
Citations -  2946

Shira G. Ziegler is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Calcification & Glucocerebrosidase. The author has an hindex of 18, co-authored 32 publications receiving 2478 citations. Previous affiliations of Shira G. Ziegler include Oberlin College & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Ellen Sidransky, +75 more
TL;DR: Data collected demonstrate that there is a strong association between GBA mutations and Parkinson's disease, and those with a GBA mutation presented earlier with the disease, were more likely to have affected relatives, and were morelikely to have atypical clinical manifestations.
Journal ArticleDOI

NT5E mutations and arterial calcifications.

TL;DR: Clinical, radiographic, and genetic studies in three families with symptomatic arterial calcifications identified nine persons with calcifications of the lower-extremity arteries and hand and foot joint capsules, all five siblings in one family, three siblings in another, and one patient in a third family.
Journal ArticleDOI

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease.

TL;DR: It is demonstrated that GBA mutations are also encountered in Chinese subjects with sporadic PD at a higher frequency than many other known PD genes.
Journal ArticleDOI

Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum.

TL;DR: The newly described role ofAdenosine in inhibiting vascular calcification, along with the similarity of ACDC and PXE with respect to vascular pathology, suggests that adenosine may be the ligand for ABCC6, a C type ABC transporter whose ligand is unknown.
Journal ArticleDOI

PKHD1 sequence variations in 78 children and adults with autosomal recessive polycystic kidney disease and congenital hepatic fibrosis.

TL;DR: Se sequencing results on 78 ARPKD/CHF patients from 68 families required survival beyond 6 months and included many adults with a CHF-predominant phenotype, achieving a mutation detection rate of 79%, and identifying 77 PKHD1 variants including 19 truncating, 55 missense, 2 splice, and 1 small in-frame deletion.